Herein we report on a new hybrid enzymatic fuel cell (EFC) based on mediated/direct electron transfer, which is assembled by considering two different configurations: i) two normal screen printed electrodes (SPEs) in one electrochemical cell and ii) two double-sided SPEs each one comprising both bioanode and biocathode, connected in series. After a deep electrodes characterization, they are assembled according to the first configuration obtaining a maximal power output of 25.8 ± 0.7 μW cm−2 at a cell voltage of 0.57 V and an open circuit voltage (OCV) of 0.78 V. Moreover, the EFC performance are substantially improved by using the second configuration (EFCs connected in series) obtaining a maximal power output of 59.6 ± 1.9 μW cm−2 at a cell voltage of 1.16 V and an open circuit voltage (OCV) of 1.58 V. Finally, the last EFC configuration is tested in human saliva and serum showing good performance in terms of OCV and maximal power output as proof-of-concept to power implantable bioelectronics (e.g., pacemaker) or develop self-powered glucose biosensors.

A glucose/oxygen enzymatic fuel cell exceeding 1.5 V based on glucose dehydrogenase immobilized onto polyMethylene blue-carbon nanotubes modified double-sided screen printed electrodes: Proof-of-concept in human serum and saliva

Bollella P.
Supervision
;
2020-01-01

Abstract

Herein we report on a new hybrid enzymatic fuel cell (EFC) based on mediated/direct electron transfer, which is assembled by considering two different configurations: i) two normal screen printed electrodes (SPEs) in one electrochemical cell and ii) two double-sided SPEs each one comprising both bioanode and biocathode, connected in series. After a deep electrodes characterization, they are assembled according to the first configuration obtaining a maximal power output of 25.8 ± 0.7 μW cm−2 at a cell voltage of 0.57 V and an open circuit voltage (OCV) of 0.78 V. Moreover, the EFC performance are substantially improved by using the second configuration (EFCs connected in series) obtaining a maximal power output of 59.6 ± 1.9 μW cm−2 at a cell voltage of 1.16 V and an open circuit voltage (OCV) of 1.58 V. Finally, the last EFC configuration is tested in human saliva and serum showing good performance in terms of OCV and maximal power output as proof-of-concept to power implantable bioelectronics (e.g., pacemaker) or develop self-powered glucose biosensors.
File in questo prodotto:
File Dimensione Formato  
Paper 53.pdf

non disponibili

Descrizione: articolo pubblicato
Tipologia: Documento in Versione Editoriale
Licenza: Copyright dell'editore
Dimensione 6.15 MB
Formato Adobe PDF
6.15 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
BFC JPS_merged.pdf

accesso aperto

Descrizione: accepted manuscript
Tipologia: Documento in Post-print
Licenza: Creative commons
Dimensione 2.81 MB
Formato Adobe PDF
2.81 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11586/422080
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 18
  • ???jsp.display-item.citation.isi??? 17
social impact